CLINICAL_TRIALS trial_result · 2023-07-12

Clinical Trial Update: TWB-103 for Treating Lower Limb Ulcers on Patients With DM [Phase 1, Phase 2]

A phase 1/2 clinical trial update for TWB-103 targeting diabetic foot ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Transwell Biotech Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-12